Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax in advanced breast cancer
NCT00227474Phase 2Withdrawn
- Sponsor
- SWOG Cancer Research Network
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of MVA-5T4 in breast cancer, sponsored by SWOG Cancer Research Network. Status: withdrawn.
02
Drugs
MVA-5T4
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00227474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227474.